openPR Logo
Press release

Acute Coronary Syndrome Market is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% | Teva Pharmaceuticals, Dr. Reddy's Laboratories, Boehringer Ingelheim.

03-10-2025 07:52 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Acute Coronary Syndrome Market

Acute Coronary Syndrome Market

The Global Acute Coronary Syndrome Market reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.

Acute Coronary Syndrome Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/acute-coronary-syndrome-market?rk

Acute Coronary Syndrome refers to a range of heart conditions caused by a sudden reduction of blood flow to the heart. This condition often results from plaque buildup in the coronary arteries, potentially leading to heart attacks or unstable angina. Symptoms may include chest pain, shortness of breath, and dizziness, requiring immediate medical attention. Treatment often involves medications such as blood thinners, beta-blockers, and emergency procedures like angioplasty. Early intervention is essential to prevent severe heart damage and improve patient outcomes.

List of the Key Players in the Acute Coronary Syndrome Market:

Teva Pharmaceuticals, Dr. Reddy's Laboratories, Boehringer Ingelheim, Johnson & Johnson, Merck, Novartis, Amgen Inc., AbbVie Inc., AstraZeneca PLC and GlaxoSmithKline Plc.

Industry Development:

In Sep 2022, Abiomed announced that U.S. FDA approved two clinical research Impella heart pumps that can be used in acute myocardial infarction.

Growth Forecast Projected:

The Global Acute Coronary Syndrome Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Acute Coronary Syndrome Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/acute-coronary-syndrome-market?rk

Segment Covered in the Acute Coronary Syndrome Market:

By Type: ST-elevation Myocardial Infarction, Non-ST-Elevation Myocardial Infarction, Unstable Angina
By Drugs: Antithrombotic, Antihypertensive, Statin Drugs
By End-User: Hospital, Specialty Clinics, Others
Regional Analysis for Acute Coronary Syndrome Market:

The regional analysis of the Acute Coronary Syndrome Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/acute-coronary-syndrome-market?rk

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Acute Coronary Syndrome market?

➠ Who are the leading manufacturers in the global Acute Coronary Syndrome industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Acute Coronary Syndrome industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Acute Coronary Syndrome market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/acute-coronary-syndrome-market?rk

Related Reports

Beta Inosine Market: https://datamintelligence.com/research-report/beta-inosine-market?rk

Albendazole Anthelmintic Drug Market: https://datamintelligence.com/research-report/albendazole-anthelmintic-drug-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Coronary Syndrome Market is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% | Teva Pharmaceuticals, Dr. Reddy's Laboratories, Boehringer Ingelheim. here

News-ID: 3906317 • Views:

More Releases from DataM Intelligence 4market Research LLP

Future of RNAi Therapeutics: Small Interfering RNAs, MicroRNAs, and Targeted Treatment Opportunities through 2031 | Silence Therapeutics, Arrowhead Pharmaceuticals, Inc, Sanofi.
Future of RNAi Therapeutics: Small Interfering RNAs, MicroRNAs, and Targeted Tre …
The Global RNAi Therapeutics Market is estimated to reach at a high CAGR 17.4% during the forecast period (2024-2031). The RNAi therapeutics market includes drugs that use RNA interference mechanisms to silence specific genes responsible for disease. These therapies offer precision treatment options for cancers, viral infections, and genetic disorders. Market growth is driven by increasing investment in biotechnology, rising prevalence of target diseases, and clinical trial advancements. Delivery systems such
United States Natural Fiber Composite Market Outlook 2024-2031: Sustainable Materials, Automotive Applications, and Industrial Growth | AERT, Beyer GmbH & Co. Kg, Procotex Corp SA
United States Natural Fiber Composite Market Outlook 2024-2031: Sustainable Mate …
Global Natural Fiber Composite Market reached US$ 327.0 Million in 2023 and is expected to reach US$ 494.3 Million by 2031, growing with a CAGR of 5.3% during the forecast period 2024-2031. The natural fiber composite market focuses on materials made by combining natural fibers such as jute, flax, hemp, or sisal with polymer matrices. These composites are used in automotive, construction, packaging, and consumer goods for lightweight, sustainable, and eco-friendly
United States Electrochemical Sensors Market Growth Outlook: Nanomaterials, Wireless Connectivity, and IoT-Enabled Solutions Shaping the Industry
United States Electrochemical Sensors Market Growth Outlook: Nanomaterials, Wire …
The Electrochemical Sensors Market is valued at a significant CAGR during the forecast period (2024-2031). The electrochemical sensors market covers devices that detect chemical species using electrochemical reactions to generate measurable signals. Applications include healthcare diagnostics, environmental monitoring, food safety, and industrial process control. Market growth is driven by demand for point-of-care testing, wearable devices, and real-time monitoring. Advances in miniaturization, nanomaterials, and wireless connectivity enhance sensor performance. Integration with IoT
United States Bauxite Market Outlook 2024-2031: Rising Aluminum Demand and Industrial Applications Driving Growth | Rio Tinto, Alcoa Corporation, Guinea Alumina Corporation.
United States Bauxite Market Outlook 2024-2031: Rising Aluminum Demand and Indus …
Global Bauxite Market reached US$ 14.8 billion in 2022 and is expected to reach US$ 19.7 billion by 2031, growing with a CAGR of 3.7% during the forecast period 2024-2031. The bauxite market involves the mining and processing of bauxite ore, the primary raw material for aluminum production. It is also used in refractory materials, abrasives, and chemicals. Market growth is driven by increasing aluminum demand in automotive, aerospace, and packaging

All 5 Releases


More Releases for Acute

Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth